Asset 1

SpecimenSeq™
FFPE Tissue

Make informed decisions on biospecimen selections with NGS-characterized FFPE Tissues.

Conduct Smarter, Faster R&D with Spcimen SEQ™

Bridging a deep understanding of molecular profiles with clinical information is critical to developing innovative precision medicine tools in oncology. SpecimenSeq makes this challenge easier for targeted oncology developers by delivering access to fully consented, ethically collected FFPE tissues that are comprehensively annotated annotated by pathology, genomic and clinical characteristics.

Inventory Report

Our SpecimenSeq™ FFPE tissue is NGS-characterized and pathogist-reviewed so you can confirm and identify biomarker targets, driver mutations, and clinically significant genomic variants faster and at any scale.  Discovery’s SpecimenSeq™ FFPE inventory includes:

Do You Need Help Finding the Right Samples?

  1. Download and review the inventory report.

  2. Identify Patient ID number(s) of any sample(s) you would like to reserve.

  3. Submit your request with the Patient ID number(s) using the web form here.

Deliverables & Characterization

BIOSPECIMEN FORMAT QUANTITY CHARACTERIZATION REPORTS
FFPE
1
  • Clinical information and pathology report
  • Key variants report
  • NGS Characterization Panels

    Oncomine Focus Assay

    The Oncomine Focus Assay is a targeted, multi-biomarker assay that enables detection of hotspots, SNVs, indels, CNVs, and gene fusions from DNA and RNA in a single workflow. View the full list of genes and fusions in this panel via the button below.

    TruSight Oncology 500

    TruSight Oncology 500 is a NGS assay that enables comprehensive genomic profiling of tumor samples. It supports identification of all relevant DNA and RNA variants implicated in various solid tumor types. View more details about this panel via the button below.

    Explore the Depths of Your Biospecimens

    Get biospecimens in the format you need – then deeply characterize them with Discovery’s customizable and scalable biomarker services based on advanced technologies, including genomics, proteomics, molecular pathology, and cell biology services.

    Contact Us Today

    Quick Links

    Technologies

    Development and Clinical
    Trial Solutions